Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E
2014-01-01 Catania, C; Conforti, F; Spitaleri, G; Barberis, M; Preda, L; Noberasco, C; Lazzari, C; Toffalorio, F; De Marinis, F; Manzotti, M; De Pas, Tm
Sex as a predictor of response to cancer immunotherapy Reply
2018-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Marco, M; Viale, G; Gelber, R; Goldhirsch, A
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review
2023-01-01 Digiacomo, N; De Pas, T; Rossi, G; Bossi, P; Stucchi, E; Conforti, F; Cocorocchio, E; Laszlo, D; Pala, L; Zattarin, E; Catania, C
Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
2021-01-01 Cocorocchio, E; Nezi, L; Gandini, S; Manzo, T; Mazzarella, L; Lotti, F; Pala, L; Gnagnarella, P; Conforti, F; Pennacchioli, E; Fierro, Mt; Ribero, S; Senetta, R; Picciotto, F; Caliendo, V; Quaglino, P; Mazzarol, G; Orsolini, Gm; Prestianni, P; Ferrucci, Pf
Thymic epithelial tumors: From biology to treatment
2020-01-01 Conforti, F; Pala, L; Giaccone, G; De Pas, T
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung
2013-01-01 Conforti, F; Catania, C; Toffalorio, F; Duca, M; Spitaleri, G; Barberis, M; Noberasco, C; Delmonte, A; Santarpia, M; Lazzari, C; De Pas, Tm
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors
2019-01-01 Conforti, F; Pala, L
The effect of patient sex on the efficacy and safety of anticancer immunotherapy
2021-01-01 Pala, L; Conforti, F
Successful treatment with avapritinib in patient with mucosal metastatic melanoma
2020-01-01 Cocorocchio, E; Pala, L; Conforti, F; Guerini-Rocco, E; De Pas, T; Ferrucci, Pf
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022-01-01 Corso, G; D'Ecclesiis, O; Magnoni, F; Mazzotta, E; Conforti, F; Veronesi, P; Sajjadi, E; Venetis, K; Fusco, N; Gandini, S
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
2021-01-01 Conforti, F; Pala, L; Pagan, E; Rocco, Eg; Bagnardi, V; Montagna, E; Peruzzotti, G; De Pas, T; Fumagalli, C; Pileggi, S; Pesenti, C; Marchini, S; Corso, G; Marchio, C; Sapino, A; Graffeo, R; Collet, L; Aftimos, P; Sotiriou, C; Piccart, M; Gelber, Rd; Viale, G; Colleoni, M; Goldhirsch, A
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19
2020-01-01 Pala, L; Conforti, F; Saponara, M; De Pas, T; Giugliano, F; Sale, Eo; Jemos, C; Rubatto, M; Agostini, A; Quaglino, P; Fava, P; Fierro, Mt; Queirolo, P
Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis
2023-01-01 Pala, L; Bagnardi, V; Tettamanzi, F; Barberis, M; Mazzarol, G; Casali, C; De Pas, T; Pennacchioli, E; Coppola, S; Baldini, F; Cocorocchio, E; Ferrucci, P; Patane', D; Saponara, M; Queirolo, P; Conforti, F
Original Research Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy
2021-01-01 Repetto, M; Conforti, F; Pirola, S; Calvello, M; Pala, L; Bonanni, B; Catania, C; Curigliano, G; De Pas, T
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
2021-01-01 Conforti, F.; Pala, L.; Pagan, E.; Bagnardi, V.; De Pas, T.; Queirolo, P.; Pennacchioli, E.; Catania, C.; Cocorocchio, E.; Ferrucci, P. F.; Saponara, M.; Orsolini, G.; Zagami, P.; Nicolo, E.; De Marinis, F.; Tortora, G.; Bria, E.; Minucci, S.; Joffe, H.; Veronesi, P.; Wargo, J.; Rosenthal, R.; Swanton, C.; Mantovani, A.; Gelber, R. D.; Viale, G.; Goldhirsch, A.; Giaccone, G.
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials A Systematic Review and Meta-analysis
2022-01-01 Pala, L; Sala, I; Oriecuia, C; De Pas, T; Queirolo, P; Specchia, C; Cocorocchio, E; Ferrucci, P; Patane, D; Saponara, M; Pennacchioli, E; Coppola, S; Viale, G; Giaccone, G; Gelber, Rd; Bagnardi, V; Conforti, F
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis
2023-01-01 Pala, L.; De Pas, T.; Stucchi, E.; Catania, C.; Cocorocchio, E.; Zampino, M. G.; Rossi, G.; Zattarin, E.; Di Muzio, A.; Laszlo, D.; Stucchi, S.; Conforti, F.
Different Response to Immunotherapy According to Melanoma Histologic Subtype
2022-01-01 Pala, L; Conforti, F; Pagan, E; Bagnardi, V; De Pas, Tm; Mazzarol, G; Barberis, M; Pennacchioli, E; Orsolini, G; Prestianni, P; Zagami, P; Nicolo', E; Patane, D; Saponara, M; Queirolo, P
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial
2020-01-01 Conforti, F; Pala, L; Pagan, E; Bagnardi, V; Zagami, P; Spaggiari, L; Catania, C; Vansteenkiste, J; Giaccone, G; De Pas, T
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis
2024-01-01 Pala, L.; Pagan, E.; Sala, I.; Oriecuia, C.; Oliari, M.; De Pas, T.; Specchia, C.; Cocorocchio, E.; Zattarin, E.; Rossi, G.; Catania, C.; Ceresoli, G. L.; Laszlo, D.; Canzian, J.; Valenzi, E.; Viale, G.; Gelber, R. D.; Mantovani, A.; Bagnardi, V.; Conforti, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E | 1-gen-2014 | Catania, C; Conforti, F; Spitaleri, G; Barberis, M; Preda, L; Noberasco, C; Lazzari, C; Toffalorio, F; De Marinis, F; Manzotti, M; De Pas, Tm | |
| Sex as a predictor of response to cancer immunotherapy Reply | 1-gen-2018 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Marco, M; Viale, G; Gelber, R; Goldhirsch, A | |
| Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review | 1-gen-2023 | Digiacomo, N; De Pas, T; Rossi, G; Bossi, P; Stucchi, E; Conforti, F; Cocorocchio, E; Laszlo, D; Pala, L; Zattarin, E; Catania, C | |
| Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome | 1-gen-2021 | Cocorocchio, E; Nezi, L; Gandini, S; Manzo, T; Mazzarella, L; Lotti, F; Pala, L; Gnagnarella, P; Conforti, F; Pennacchioli, E; Fierro, Mt; Ribero, S; Senetta, R; Picciotto, F; Caliendo, V; Quaglino, P; Mazzarol, G; Orsolini, Gm; Prestianni, P; Ferrucci, Pf | |
| Thymic epithelial tumors: From biology to treatment | 1-gen-2020 | Conforti, F; Pala, L; Giaccone, G; De Pas, T | |
| EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung | 1-gen-2013 | Conforti, F; Catania, C; Toffalorio, F; Duca, M; Spitaleri, G; Barberis, M; Noberasco, C; Delmonte, A; Santarpia, M; Lazzari, C; De Pas, Tm | |
| Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors | 1-gen-2019 | Conforti, F; Pala, L | |
| The effect of patient sex on the efficacy and safety of anticancer immunotherapy | 1-gen-2021 | Pala, L; Conforti, F | |
| Successful treatment with avapritinib in patient with mucosal metastatic melanoma | 1-gen-2020 | Cocorocchio, E; Pala, L; Conforti, F; Guerini-Rocco, E; De Pas, T; Ferrucci, Pf | |
| Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis | 1-gen-2022 | Corso, G; D'Ecclesiis, O; Magnoni, F; Mazzotta, E; Conforti, F; Veronesi, P; Sajjadi, E; Venetis, K; Fusco, N; Gandini, S | |
| Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations | 1-gen-2021 | Conforti, F; Pala, L; Pagan, E; Rocco, Eg; Bagnardi, V; Montagna, E; Peruzzotti, G; De Pas, T; Fumagalli, C; Pileggi, S; Pesenti, C; Marchini, S; Corso, G; Marchio, C; Sapino, A; Graffeo, R; Collet, L; Aftimos, P; Sotiriou, C; Piccart, M; Gelber, Rd; Viale, G; Colleoni, M; Goldhirsch, A | |
| Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 | 1-gen-2020 | Pala, L; Conforti, F; Saponara, M; De Pas, T; Giugliano, F; Sale, Eo; Jemos, C; Rubatto, M; Agostini, A; Quaglino, P; Fava, P; Fierro, Mt; Queirolo, P | |
| Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis | 1-gen-2023 | Pala, L; Bagnardi, V; Tettamanzi, F; Barberis, M; Mazzarol, G; Casali, C; De Pas, T; Pennacchioli, E; Coppola, S; Baldini, F; Cocorocchio, E; Ferrucci, P; Patane', D; Saponara, M; Queirolo, P; Conforti, F | |
| Original Research Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy | 1-gen-2021 | Repetto, M; Conforti, F; Pirola, S; Calvello, M; Pala, L; Bonanni, B; Catania, C; Curigliano, G; De Pas, T | |
| Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion | 1-gen-2021 | Conforti, F.; Pala, L.; Pagan, E.; Bagnardi, V.; De Pas, T.; Queirolo, P.; Pennacchioli, E.; Catania, C.; Cocorocchio, E.; Ferrucci, P. F.; Saponara, M.; Orsolini, G.; Zagami, P.; Nicolo, E.; De Marinis, F.; Tortora, G.; Bria, E.; Minucci, S.; Joffe, H.; Veronesi, P.; Wargo, J.; Rosenthal, R.; Swanton, C.; Mantovani, A.; Gelber, R. D.; Viale, G.; Goldhirsch, A.; Giaccone, G. | |
| Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials A Systematic Review and Meta-analysis | 1-gen-2022 | Pala, L; Sala, I; Oriecuia, C; De Pas, T; Queirolo, P; Specchia, C; Cocorocchio, E; Ferrucci, P; Patane, D; Saponara, M; Pennacchioli, E; Coppola, S; Viale, G; Giaccone, G; Gelber, Rd; Bagnardi, V; Conforti, F | |
| Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis | 1-gen-2023 | Pala, L.; De Pas, T.; Stucchi, E.; Catania, C.; Cocorocchio, E.; Zampino, M. G.; Rossi, G.; Zattarin, E.; Di Muzio, A.; Laszlo, D.; Stucchi, S.; Conforti, F. | |
| Different Response to Immunotherapy According to Melanoma Histologic Subtype | 1-gen-2022 | Pala, L; Conforti, F; Pagan, E; Bagnardi, V; De Pas, Tm; Mazzarol, G; Barberis, M; Pennacchioli, E; Orsolini, G; Prestianni, P; Zagami, P; Nicolo', E; Patane, D; Saponara, M; Queirolo, P | |
| Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial | 1-gen-2020 | Conforti, F; Pala, L; Pagan, E; Bagnardi, V; Zagami, P; Spaggiari, L; Catania, C; Vansteenkiste, J; Giaccone, G; De Pas, T | |
| Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis | 1-gen-2024 | Pala, L.; Pagan, E.; Sala, I.; Oriecuia, C.; Oliari, M.; De Pas, T.; Specchia, C.; Cocorocchio, E.; Zattarin, E.; Rossi, G.; Catania, C.; Ceresoli, G. L.; Laszlo, D.; Canzian, J.; Valenzi, E.; Viale, G.; Gelber, R. D.; Mantovani, A.; Bagnardi, V.; Conforti, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26842
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269046
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS226
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE181
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19414
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19124
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24589
- reserved1362
- open891